novavax fda - Search News

News

Novavax, COVID-19 vaccine and FDA

Reuters on MSN · 2h

US FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports

(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously delaying approval, the Wall Street Journal reported on Friday, citing people familiar with the matter.

MarketWatch · 3h

Novavax Slips After WSJ Report on FDA Request for Another Vaccine Study

Novavax shares declined after a Wall Street Journal report that federal regulators are asking the company to complete an additional randomized clinical trial on its Covid-19 vaccine, according to people familiar with the matter.

The Associated Press on MSN · 2d

Novavax says its COVID-19 shot is on track for full FDA approval after delay

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the Food and Drug Administration

2don MSN

Novavax shares soar after FDA request raises hope for COVID vaccine approval

Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...

Investing.com South Africa4h

Novavax shares fall following WSJ report on FDA trial request

Novavax (NASDAQ: NVAX) shares declined 6% following a report from the Wall Street Journal that said federal regulators are ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results